BRCA1 and breast cancer: Indeed, Molyneux and colleagues found that ERneg luminal progenitors, and not basal stem cells, when targeted with a Brca1 mutation in mice, can yield mammary tumors that closely resemble human BRCA1 mutant (basal-like) breast cancer, at least by histological examination [5].